Testing effectiveness (Phase 2)Ended earlyNCT00593554
What this trial is testing
Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies
Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more
Sherif S. Farag 9